|
Mean carnosinase activity in the without dementia, AD and MD groups after removal of medical conditions (Table 1) |
|||
| Medical condition removed |
Carnosinase (μmol/ml/h) |
||
|
|
|||
| Without dementia |
AD |
MD |
|
|
|
|||
| None |
40.3 |
44.4 |
26.6** |
| Arthritis |
35.8 |
47.0 |
22.0* |
| Cardiovascular disease |
41.2 |
41.6 |
21.4* |
| Depression |
41.5 |
44.5 |
26.2* |
| Diabetes |
36.6 |
44.5 |
28.7* |
| Hypothyroidism, treated |
40.3 |
42.6 |
26.6* |
| Parkinson's Disease |
38.9 |
44.4 |
26.6** |
| Renal insufficiency |
39.0 |
44.4 |
27.6* |
| Stroke, history |
40.3 |
44.4 |
26.6** |
| TIA, history |
39.0 |
43.2 |
19.4‡*** |
|
AD, Alzheimer's disease; MD, mixed dementia. * p-value < 0.05, ** p-value = 0.01, *** p-value = 0.001 between AD and MD ‡ p-value = 0.01 between MD and without dementia | |||
Balion et al. BMC Neurology 2007 7:38 doi:10.1186/1471-2377-7-38 |
|||